After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Award
Calculated transaction value
$0

Sabba Stephen L Director

Transaction date Jun 5, 2026
Public filing date Jun 9, 2026
Filing lag Filed 4 days later

LGND daily price context

Close on/before transaction
$237 Jun 5, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Non-Qualified Stock Option (right to buy) on Common Stock
Quantity / price
2,938 shares @ $0
SEC ownership
Direct
Transaction code
A
Form
4
Filing identifier
0002001011-26-000100
Filing cohort

Transactions in this filing

Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Ligand Pharmaceuticals Inc LGND Award Jun 5, 2026 $0
Ligand Pharmaceuticals Inc LGND Current Award Jun 5, 2026 $0